WC

William Canestaro

Healthcare and Biotech Investor | Advisor | Executive | Board Member

Seattle, Washington

Invests in

  • Min Investment:

    $100,000.00
  • Max Investment:

    $5,000,000.00
  • Target Investment:

    $1,500,000.00

Education

Work Experience

  • Advisor

    2024

  • Managing Director

    2018 - 2024

  • Manager, Strategic Investments

    2016 - 2018

  • Consultant

    2016 - 2016

  • Marshall Memorial Fellow

    2022

  • Better Arguments Ambassador

    2022

  • Member, Corporate Advisory Board

    2018

  • Affiliate Faculty

    2018

  • Advisor to WRF Health Economic and Outcomes Research Fellowship

    2018

    The WRF-HEOR Fellowship aims to connect qualified researchers to meaningful health economic challenges facing Washington State life science companies. Health economics and outcomes research (HEOR) is increasingly being used at earlier stages of product development for healthcare and life sciences to inform decision making. While this expertise is commonly available at larger companies it may be unaffordable to smaller companies that have arguably the greatest need for that kind of service. The WRF-HEOR Fellowship would aim to address this gap by providing high-quality health economic and outcomes research services to WRF mission-related companies coming from qualified institutions in Washington state while also providing a valuable training activity for graduate students at Washington state research institutions.

  • Teaching Faculty for Systematic Reviews and Meta-Analyses

    2020 - 2023

    Designed and taught PHARM 540: Systematic Reviews and Meta-Analyses in the UW School of Pharmacy.

  • Teaching Faculty-Health Innovation

    2018

    This course is designed to give students an overview of the challenges that are necessary for any young business in healthcare or life sciences to consider. By the end of the course, students should expect to have an awareness of the system of regulation of health technologies, the process of development for health technologies, and the economics of healthcare. https://foster.uw.edu/centers/buerk-ctr-entrepreneurship/entrepreneurship-competitions/uw-health-innovation-challenge/

2023 - 2024

  • Member Board of Directors

    2023 - 2024

  • Member Board of Directors

    2023 - 2024

2017 - 2018

  • Consultant

    2017 - 2018

Veritech Corporation

2013 - 2017

  • Health Economic Consultant and Modeler

    2013 - 2017

    Health economics and outcomes research consultant for clients including: MedImmune/AstraZeneca, Genentech, and the National Pharmaceutical Council. Involved in generation of numerous drug's economic evidence for AMCP dossier.

  • Research Assistant

    2014 - 2015

    Research assistant for the NIH funded Personalized Medicine Economics Research (PriMER) project. My responsibilities involved organization, execution and analysis of focus groups and interviews with patients, providers and payers on the value of companion diagnostics and personalized medicines to healthcare consumers.